Valery Krylov Selected Research

Samarium-153

1/2013	Optimal timing of bisphosphonate administration in combination with samarium-153 oxabifore in the treatment of painful metastatic bone disease.
1/2013	Effectiveness of bone metastases treatment by sm-153 oxabifore in combination with monoclonal antibody denosumab (xgeva): first experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valery Krylov Research Topics

Disease

2	Pain (Aches) 01/2013 - 01/2013
2	Neoplasm Metastasis (Metastasis) 01/2013 - 01/2013
1	Bone Diseases (Bone Disease) 01/2013
1	Neoplasms (Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

2	Samarium-153IBA 01/2013 - 01/2013
1	Diphosphonates (Bisphosphonates)IBA 01/2013
1	Radioisotopes (Radionuclides)IBA 01/2013
1	Denosumab FDA Link 01/2013
1	Zoledronic Acid (Zometa)FDA Link 01/2013
1	Monoclonal AntibodiesIBA 01/2013

Therapy/Procedure

2	Aftercare (After-Treatment) 01/2013 - 01/2013
1	Therapeutics 01/2013